Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial

Clicks: 527
ID: 116602
2003
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #23 of 545 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 545 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The efficacy and safety of high-dose intravenous polyspecific immunoglobulin G (IVIG) as adjunctive therapy in streptococcal toxic shock syndrome (STSS) were evaluated in a multicenter, randomized, double-blind, placebo-controlled trial. The trial was prematurely terminated because of slow patient r …
Reference Key
j2003clinicalintravenous Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Darenberg J;Ihendyane N;Sjölin J;Aufwerber E;Haidl S;Follin P;Andersson J;Norrby-Teglund A; ;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2003
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/12884156
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't adult female male aged middle aged 80 and over Clinical Trial Randomized Controlled Trial Double-Blind Method Multicenter Study immunoglobulins immunoglobulin g / therapeutic use* intravenous shock streptococcal infections / mortality pmid:12884156 doi:10.1086/376630 jessica darenberg nahla ihendyane streptig study group septic / microbiology septic / mortality septic / therapy* streptococcal infections / therapy*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.